New global initiative urges patients and clinicians to wait for biomarker testing results before starting treatment.

The Global Cancer Biomarkers Market is projected to grow at a CAGR of 8.6% from 2026 to 2033, according to a new report published by Verified Market Reports®. The report reveals that the market was ...

Strategy is feasible for advanced cancers; 157 regimens were administered to 210 patients, including 103 personalized combos ...

A newly developed radiopharmaceutical pair can precisely detect and effectively treat gastric and pancreatic tumors, ...

Advancing Superior Accuracy in Early Lung Cancer Detection Using Selective Metabolic Pathways and Data Enrichment for ...

The only potentially curative options for gastric cancer involve endoscopic or surgical resection, with adjunctive systemic ...

The first patient has been dosed in the TROPION-Lung17 phase 3 trial evaluating DATROWAY® (datopotamab deruxtecan) compared ...

HPV status, particularly combined p16 and HPV positivity, is vital for patient selection in de-escalation strategies for ...

Researchers at Tezpur University, Assam, have discovered chemical signatures in blood that distinguish gallbladder cancer ...

Recreational physical activity may be associated with breast tissue composition and biomarkers of stress in adolescent girls, according to a new study from Columbia University Mailman School of Public ...

Cancer immunity and immunotherapy research increasingly recognizes that chronic inflammation is a major driver of tumorigenesis, yet the complex and dynamic ...

Biomarker testing has become “increasingly critical” in the care of non-small cell lung cancer.A new investigation into testing rates proved “reassuring” to Kenneth L. Kehl, MD, MPH, assistant ...